Post

New research · Ophthalmology
Translational vision science & technology · 16h
StudyTranslational vision science & technology · 2026

Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues.

Saumya Jakati, Tirupathi Rao Mocherla, Rani Pallavi … Swathi Kaliki
Read paper
OphthalmologyStudy

TSG101 extracellular vesicle marker was expressed in 92% of retinoblastoma tumors.

Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues.

Saumya Jakati … Swathi Kaliki
Translational vision science & technology · 2026
Purpose

To evaluate the expression of small extracellular vesicle (sEV)-specific markers in retinoblastoma (retinoblastoma) tumor tissue and to identify the retinoblastoma-specific extracellular cargo as biomarker.

Methods

Twenty-five treatment-naïve, unilateral retinoblastoma were included in the study from ophthalmic pathology achieves during January 2020 to December 2022.

n = 11
Results

expression of a tumor-linked marker was found in almost all tumors

44%
CD63
92%
TSG101
More results

CD81 was the least expressed.

Of the sEV cargo, HIF1a (n = 22, 88%) followed by KAT2B (n = 21 [84%]) showed increased expression in tumor cells with no expression in normal retina.

Vascular endothelial growth factor A was seen in 48% of cases and was expressed in normal retina.

All the markers showed heterogenous expression in the tumor.

“
Conclusion · 1 of 2

Although sEV markers are expressed in tumor microenvironment, their expression is heterogenous in tumors. Of the EV markers, tetraspanin CD63 was predominantly expressed in tumor tissues as compared with CD9 and CD81.

Conclusion · 2 of 2

Among the previously identified EV cargo, HIF1a and KAT2B were found to be expressed in retinoblastoma tumors, indicating their potential as biomarkers.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving